Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Recombinant Human Insulin Like Growth Factor-1 (rhIGF-1) on Bone Metabolism in Adolescent Girls With Anorexia Nervosa

NCT00720122 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00720122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00720122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Recombinant Human Insulin Like Growth Factor-1 (rhIGF-1) on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
October 31, 2011
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of bone density and structure, unspecified